Jan. 1, 2014
China will institute an official publically-available blacklist-system of drug makers and medical device manufacturers to punish them for bribing officials. The new measure was announced by the National Health and Family Planning Commission (“NHFPC”) on Dec. 2013 and shall become operative on March 1, 2014. It will prevent a company from selling its products in any Province in which it was implicated for a period of two years. Should the company commit two infractions in a five-year period, it will be banned from selling its products anywhere in China, also for two years.